These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37124096)

  • 1. Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9.
    Allen AG; Chung CH; Worrell SD; Nwaozo G; Madrid R; Mele AR; Dampier W; Nonnemacher MR; Wigdahl B
    Front Genome Ed; 2023; 5():1101483. PubMed ID: 37124096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.
    Darcis G; Binda CS; Klaver B; Herrera-Carrillo E; Berkhout B; Das AT
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30871200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir.
    Roychoudhury P; De Silva Feelixge H; Reeves D; Mayer BT; Stone D; Schiffer JT; Jerome KR
    BMC Biol; 2018 Jul; 16(1):75. PubMed ID: 29996827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9 System with Dual gRNAs Synergically Inhibit Hepatitis B Virus Replication.
    Fei L; Sun S; Yang Q; Huang Y; Li Q; Tao S; Chen L
    Discov Med; 2024 Jun; 36(185):1169-1179. PubMed ID: 38926103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.
    Herskovitz J; Hasan M; Patel M; Blomberg WR; Cohen JD; Machhi J; Shahjin F; Mosley RL; McMillan J; Kevadiya BD; Gendelman HE
    EBioMedicine; 2021 Nov; 73():103678. PubMed ID: 34774454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy.
    Chung CH; Allen AG; Atkins A; Link RW; Nonnemacher MR; Dampier W; Wigdahl B
    Front Cell Infect Microbiol; 2021; 11():593077. PubMed ID: 33768011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites.
    Chung CH; Allen AG; Atkins AJ; Sullivan NT; Homan G; Costello R; Madrid R; Nonnemacher MR; Dampier W; Wigdahl B
    Mol Ther Nucleic Acids; 2020 Sep; 21():965-982. PubMed ID: 32818921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.
    Smith LM; Ladner JT; Hodara VL; Parodi LM; Harris RA; Callery JE; Lai Z; Zou Y; Raveedran M; Rogers J; Giavedoni LD
    J Virol; 2021 Nov; 95(23):e0088221. PubMed ID: 34549979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics.
    Dampier W; Sullivan NT; Mell JC; Pirrone V; Ehrlich GD; Chung CH; Allen AG; DeSimone M; Zhong W; Kercher K; Passic S; Williams JW; Szep Z; Khalili K; Jacobson JM; Nonnemacher MR; Wigdahl B
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):950-960. PubMed ID: 29968495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed
    Ophinni Y; Miki S; Hayashi Y; Kameoka M
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33126728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.
    Hu W; Kaminski R; Yang F; Zhang Y; Cosentino L; Li F; Luo B; Alvarez-Carbonell D; Garcia-Mesa Y; Karn J; Mo X; Khalili K
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11461-6. PubMed ID: 25049410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of CRISPR/Cas9 Guide RNA Efficiency and Specificity Against Genetically Diverse HIV-1 Isolates.
    Sessions KJ; Chen YY; Hodge CA; Hudson TR; Eszterhas SK; Hayden MS; Howell AL
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):862-874. PubMed ID: 32640832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure.
    Dampier W; Nonnemacher MR; Sullivan NT; Jacobson JM; Wigdahl B
    MOJ Immunol; 2014 Oct; 1(4):. PubMed ID: 25893217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.
    Ophinni Y; Inoue M; Kotaki T; Kameoka M
    Sci Rep; 2018 May; 8(1):7784. PubMed ID: 29773895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV-1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication.
    Ueda S; Ebina H; Kanemura Y; Misawa N; Koyanagi Y
    Microbiol Immunol; 2016 Jul; 60(7):483-96. PubMed ID: 27278725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS.
    Yin C; Zhang T; Li F; Yang F; Putatunda R; Young WB; Khalili K; Hu W; Zhang Y
    AIDS; 2016 May; 30(8):1163-74. PubMed ID: 26990633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
    Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
    Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing.
    Gao Y; Zhao Y
    J Integr Plant Biol; 2014 Apr; 56(4):343-9. PubMed ID: 24373158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication.
    Zhang J; Zhang Y; Khanal S; Cao D; Zhao J; Dang X; Nguyen LNT; Schank M; Wu XY; Jiang Y; Ning S; Wang L; El Gazzar M; Moorman JP; Guo H; Yao ZQ
    J Med Virol; 2023 Jul; 95(7):e28952. PubMed ID: 37455550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.